Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4823 studies found for:    stage 2 breast cancer
Show Display Options
RSS Create an RSS feed from your search for:
stage 2 breast cancer
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
Condition: Breast Cancer
Intervention: Drug: docetaxel & capecitabine
2 Completed Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
3 Completed Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
Conditions: Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Biological: Autologous dendritic cell vaccination
4 Active, not recruiting Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
Condition: Breast Cancer
Intervention:
5 Completed Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: aldesleukin;   Biological: recombinant interferon gamma;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
6 Recruiting Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
Conditions: Breast Cancer;   Breast Cancer Stage II-III
Intervention: Drug: Docetaxel- Carboplatin
7 Terminated S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: radiation therapy;   Procedure: surgery
8 Completed Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CMF regimen;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: autologous bone marrow transplantation;   Procedure: surgical procedure;   Radiation: radiation therapy
9 Recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: PD0332991;   Drug: Anastrozole;   Drug: Goserelin;   Procedure: Surgery (standard of care);   Procedure: Tumor biopsy
10 Completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
11 Active, not recruiting Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Nab-paclitaxel
12 Active, not recruiting Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Condition: Breast Cancer
Interventions: Biological: HER2Bi-armed activated T cells;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
13 Completed Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: DLBS1425;   Drug: Placebo DLBS1425
14 Completed Biomarkers in Women Receiving Chemotherapy and Celecoxib for Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: capecitabine;   Drug: celecoxib;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: imaging biomarker analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: needle biopsy;   Procedure: neoadjuvant therapy;   Procedure: radiomammography;   Procedure: ultrasound imaging
15 Unknown  Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
16 Terminated Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Paclitaxel/Gemcitabine
17 Completed Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Post-operative adjuvant therapy;   Drug: neoadjuvant therapy;   Procedure: therapeutic surgical procedure;   Radiation: Radiation therapy with concurrent Paclitaxel;   Drug: Hormonal Therapy
18 Completed
Has Results
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Condition: Breast Neoplasm
Interventions: Drug: epirubicin;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: trastuzumab
19 Completed Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: pegfilgrastim;   Drug: carboplatin;   Drug: docetaxel;   Procedure: conventional surgery
20 Terminated
Has Results
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: goserelin acetate;   Drug: letrozole;   Drug: anastrozole;   Drug: chemotherapy;   Procedure: Surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.